News

Abbott diet drug study renews calls for U.S. ban (Reuters)

Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.

Go here to see the original:
Abbott diet drug study renews calls for U.S. ban
(Reuters)

Americans Blind to the Obesity Epidemic (HealthDay)

HealthDay – THURSDAY, Sept. 2 (HealthDay News) — Many Americans have skewed perceptions when it comes to their weight, often believing they are lighter than they actually are, even when the scales are shouting otherwise, a new poll finds.

Here is the original post: 
Americans Blind to the Obesity Epidemic
(HealthDay)

Abbott’s diet drug study renews calls for U.S. ban (Reuters)

Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.

The rest is here:
Abbott’s diet drug study renews calls for U.S. ban
(Reuters)

Exercise Can Counteract Obesity Genes, Says Study (Time.com)

Time.com – A new study finds people who are genetically predisposed to obesity may benefit most from physical activity

Read more here: 
Exercise Can Counteract Obesity Genes, Says Study
(Time.com)

Study: Diet Drug Meridia May Boost Heart Risks (Time.com)

Time.com – A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke

The rest is here: 
Study: Diet Drug Meridia May Boost Heart Risks
(Time.com)

Diet Pill Meridia Ups Heart Attack Risk: Study (HealthDay)

HealthDay – WEDNESDAY, Sept. 1 (HealthDay News) — A new study is linking the popular weight loss drug Meridia to an increased risk of non-fatal heart attacks and stroke, although taking the drug did not seem to up the risk of death in patients with a history of heart problems.

Original post:
Diet Pill Meridia Ups Heart Attack Risk: Study
(HealthDay)

Corrected: Abbott’s diet drug study renews calls for U.S. ban (Reuters)

Reuters – A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.

Read the original:
Corrected: Abbott’s diet drug study renews calls for U.S. ban
(Reuters)

Too little sleep bad for teenagers’ diets: study (Reuters)

Reuters – Teenagers who sleep less than eight hours a night on weeknights eat more fatty foods and snacks than those who get more than eight hours of sleep a night, U.S. researchers said on Wednesday.

More here: 
Too little sleep bad for teenagers’ diets: study
(Reuters)

Exercise cuts genetic obesity risk by 40 percent: study (AFP)

AFP – Physical exercise can reduce a genetic predisposition to obesity by an average of 40 percent, a new study showed.

Read more from the original source: 
Exercise cuts genetic obesity risk by 40 percent: study
(AFP)

Active Lifestyle May Help Counter Obesity Genes (HealthDay)

HealthDay – TUESDAY, Aug. 31 (HealthDay News) — Exercise can reduce a person’s genetic predisposition to obesity by 40 percent, finds a new English study.

Here is the original:
Active Lifestyle May Help Counter Obesity Genes
(HealthDay)

Next Page »